REFERENCES
- Green W R, Wilson D J. Choroidal neovascularization. Ophthalmology. 1986; 93: 1169–1176, [PUBMED], [INFOTRIEVE], [CSA]
- Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. Two-year results of 2 randomized clinical trials. TAP Report 2. Arch Ophthalmol. 2001; 119: 198–207, [CSA]
- Verteporfin in Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of randomized clinical trial including lesions with occult with no classic choroidal neovascularization. Verteporfin in Photodynamic Therapy Report 2. Am J Ophthalmol. 2001; 131: 541–560, [CSA]
- Verteporfin in Photodynamic Therapy (VIP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin: 1-year results of a randomized clinical trial. VIP report No. 1. Ophthalmology. 2001; 108: 841–852, [CSA]
- Coquelet P, Postelmans L, Snyers B, Verougstraete C. Successful photodynamic therapy combined with laser photocoagulation in three eyes with classic subfoveal choroidal neovascularisation affecting two patients with multifocal choroiditis: case reports. Bull Soc Belge Ophtalmol. 2002; 283: 69–73, [PUBMED], [INFOTRIEVE], [CSA]
- Brown J, Folk J C, Reddy C V, Kimura A E. Visual prognosis of multifocal choriditis, punctate inner choroidopathy, and the diffuse subretinal fibrosis syndrome. Ophthalmology. 1996; 103: 1100–1105, [PUBMED], [INFOTRIEVE], [CSA]
- Lewis M, Van Newkirk M, Gass J. Follow up study of presumed ocular histoplasmosis syndrome. Ophthalmology. 1980; 87: 390–399, [PUBMED], [INFOTRIEVE], [CSA]
- Olk R J, Burgess D B, Cormick P A. Subfoveal and juxtafoveal subretinal neovascularization in the presumed ocular histoplasmosis syndrome. Visual prognosis. Ophthalmology. 1984; 91: 1592–1602, [PUBMED], [INFOTRIEVE], [CSA]
- Saperstein D A, Rosenfeld P J, Bressler N M, et al. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome. One-year results of an uncontrolled, prospective case series. Ophthalmology. 2002; 109: 1499–1505, [PUBMED], [INFOTRIEVE], [CSA]
- Busquets M A, Shah G K, Winckens J, et al. Ocular photodynamic therapy with verteporfin for choroidal neovascularization secondary to ocular histoplasmosis syndrome. Retina. 2003; 23: 299–306, [PUBMED], [INFOTRIEVE], [CSA]
- Rogers A H, Duker J S, Nichols N, et al. Photodynamic therapy of idiopathic and inflammatory choroidal neovascularization in young adults. Ophthalmology. 2003; 110: 1315–1320, [PUBMED], [INFOTRIEVE], [CSA]
- Flaxel C J, Owens S L, Mulholland B, et al. The use of corticosteroids for choroidal neovascularisation in young patients. Eye. 1998; 12: 266–272, [PUBMED], [INFOTRIEVE], [CSA]
- Thomas M A, Dickinson J D, Melberg N S, et al. Visual results after surgical removal of subfoveal choroidal neovascular membranes. Ophthalmology. 1994; 101: 1384–1396, [PUBMED], [INFOTRIEVE], [CSA]
- Fujii G Y, Humayun M S, Pieramici D J, et al. Initial experience of inferior limited macular translocation for subfoveal choridal neovascularization resulting from causes other than age-related macular degeneration. Am J Ophthalmol. 2001; 131: 90–100, [PUBMED], [INFOTRIEVE], [CSA]
- Lit E S, Kim R Y, D'Amico D J. Surgical removal of subfoveal choroidal neovascularization without removal of posterior hyaloid. A consecutive series in younger patients. Retina. 2001; 21: 317–323, [PUBMED], [INFOTRIEVE], [CSA]